Skip to main content
. 2001 Sep;45(9):2643–2647. doi: 10.1128/AAC.45.9.2643-2647.2001

TABLE 1.

Drugs, conditions, and results of compatibility studies mimicking the coadministration of ceftazidime with other drugs through the same line of infusiona

Drug Dose (mg) Vol per administration (ml) Time of infusion (h) Drug:ceftazidime ratio in final infusate
Resultb
Wt ratio Molar ratio
Anti-infectives
 Amikacin 1,500c 100 0.25 27.7 25.9 c
 Isepamicin 1,500c 100 0.25 27.7 26.6 c
 Tobramycin 600d 100 0.25 11.1 12.9 c
 Gentamicin 600d 100 0.25 11.1 13.1 c
 Vancomycin 1,500 50 1 9.0 3.3 I (phys)*
 Erythromycin 1,000 20 0.33 13.9 10.3 I (phys)*
100 0.33 12.4 9.2 c+
 Clarithromycin 500 10 0.33 12.4 9.2 I (phys)*
50 0.33 12.4 9.2 c+
 Fluconazole 200 100 0.5 1.59 2.8 c
Sedatives/anticonvulsants
 Ketamine 480 48 24 0.08 0.19 c
 Propofol 300 300 24 0.05 0.17 I (phys)**
 Sufentanil 0.12 24 24 1.98 2.8 c
 Midazolam 600 120 24 0.1 0.17 I (phys)*
 Valproic acid 1,200 12 24 0.2 0.76 c
Antihypertensives/diuretics
 Nicardipine 120 120 24 0.02 0.02 I (phys)*
 Uradipil 2,400 480 24 0.4 0.56 c
 Furosemide 960 96 24 0.16 0.26 c
Miscellaneous
N-Acetylcystein 10,000 100 24 1.7 5.69 I (chim)
 Amino acid solution 18,000e 1,000 24 30.1 c
a

All conditions are meant to mimic one administration to a patient with a body weight of 100 kg; ceftazidime was assumed to be infused at a rate of 4 g/24 h in a volume of 48 ml. 

b

c, compatible (c+, very slight precipitate with complete recovery of ceftazidime upon dilution); I (phys), physically incompatible [I (phys)*, immediate precipitation; I (phys)**, trapping in emulsion]; I (chem), chemically incompatible (>10% ceftazidime degradation). 

c

Dose, 15 mg/kg of body weight once daily. 

d

Dose, 6 mg/kg, once daily. 

e

VAMIN (standard amino acid solution for parenteral nutrition). Dose was 18 g of amino acid nitrogen/liter.